NCT05892003

Brief Summary

The investigators present a weight loss diet intervention study, to be conducted as a within-subject design, with all food and beverages provided, to assess interaction of non-nutritive sweetener (sucralose) with a high-fibre weight loss diet, on markers of gut health in humans. This study will allow assessment of the effects of a non-nutritive sweetener (sucralose) with a high-fibre (soluble fibre, fructo-oligosaccharides, FOS) diet on metabolic health and activity and composition of gut microbiota, by a controlled human diet intervention study. The investigators propose to recruit participants living with obesity, with a poor diet quality (moderate habitual fibre intake) to additionally address diet inequalities in the research approach, and this will also allow examine the time-course of adaptation of the gut microbiome (measured in faecal samples). The investigators will also assess changes in free-living glycaemic control with addition of dietary fibre and bio-markers of health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 12, 2023

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 17, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 7, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 16, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 16, 2024

Completed
Last Updated

January 7, 2025

Status Verified

January 1, 2025

Enrollment Period

1.6 years

First QC Date

May 17, 2023

Last Update Submit

January 6, 2025

Conditions

Keywords

fibrenon-nutritive sweetenerweight lossgut microbiomeglycaemic control

Outcome Measures

Primary Outcomes (3)

  • Change in gut metabolites (from faecal samples) in response to dietary fibre and non-nutritive sweetener

    Measured by changes in faecal short chain fatty acids concentrations

    At baseline and end of each arm (study days 1, 15, 29 and 43)

  • Change in gut microbiome composition (from faecal samples) in response to dietary fibre and non-nutritive sweetener

    Measured by changes in bacterial 16S ribosomal ribonucleic acid gene sequencing; 16S rRNA

    At baseline and end of each arm (study days 1, 15, 29 and 43)

  • Change in gut metabolite production (from faecal samples) in response to dietary fibre and non-nutritive sweetener

    Measured by changes in calprotectin concentrations

    At baseline and end of each arm (study days 1, 15, 29 and 43)

Secondary Outcomes (2)

  • Change in free-living glycaemic control in response to dietary fibre and non-nutritive sweetener

    every day of study diets (42days)

  • Change in glycaemic control in response to dietary fibre and non-nutritive sweetener

    At baseline and end of each arm (study days 1, 15, 29 and 43)

Other Outcomes (22)

  • Change in concentration of blood metabolites in response to dietary fibre and non-nutritive sweetener

    At baseline and end of each arm (study days 1, 15, 29 and 43)

  • Change in concentration of gut hormones in response to dietary fibre and non-nutritive sweetener

    At baseline and end of each arm (study days 1, 15, 29 and 43)

  • Change in lipid profile in response to dietary fibre and non-nutritive sweetener

    At baseline and end of each arm (study days 1, 15, 29 and 43)

  • +19 more other outcomes

Study Arms (1)

Control-High Fibre Weight Loss-High Fibre Non-Nutritive Sweetener Weight Loss: CTRL-HF WL-HF-NNS WL

EXPERIMENTAL

* Phase 1 CTRL: Control diet with moderate fibre consumption for 14days. * Phase 2 HF WL: High Fibre Weight Loss meal consumption for 14days. * Phase 3 HF-NNS WL: High Fibre and Non-Nutritive Sweetener Weight Loss meal consumption for 14days.

Other: Phase 1 ControlOther: Phase 2 High Fibre Weight LossOther: Phase 3 High Fibre and Non-Nutritive Sweetener Weight Loss

Interventions

Control diet (30% Fat, 15% Protein, 55% Carbohydrate, Fibre rising from 10 to 16g/d). Fed to energy balance (1.5 x Resting Metabolic Rate, RMR).

Also known as: CTRL
Control-High Fibre Weight Loss-High Fibre Non-Nutritive Sweetener Weight Loss: CTRL-HF WL-HF-NNS WL

High Fibre Weight Loss diet (30% Fat, 15% Protein, 55% Carbohydrate). Fed to energy deficit (100% RMR). The quantity of fructo-oligosaccharides (FOS) will be fixed at 20g/day for all kcal levels with additional fibre coming from the diet provided. The FOS will be split over breakfast, lunch and dinner in drinks/yoghurts which will be compulsory to consume.

Also known as: HF WL
Control-High Fibre Weight Loss-High Fibre Non-Nutritive Sweetener Weight Loss: CTRL-HF WL-HF-NNS WL

High Fibre and Non-Nutritive Sweetener Weight Loss diet (30% Fat, 15% Protein, 55% Carbohydrate). Fed to energy deficit (100% RMR). The quantity of fructo-oligosaccharides (FOS) and non-nutritive sweetener (sucralose) will be fixed at 20g/day and 30mg/day respectively for all kcal levels with additional fibre coming from the diet provided. The FOS and sucralose will be split over breakfast, lunch and dinner in drinks/yoghurts which will be compulsory to consume.

Also known as: HF-NNS WL
Control-High Fibre Weight Loss-High Fibre Non-Nutritive Sweetener Weight Loss: CTRL-HF WL-HF-NNS WL

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • healthy but overweight/obese (BMI 28-40kg/m2) males and females (postmenopausal, using the oral contraceptive pill or some form of hormonal contraceptive)
  • moderate habitual fibre intake (18-23g/day)

You may not qualify if:

  • antibiotic use (within the past 3 months due to impact on gut microbiota)
  • anti-depressants (current)
  • smoking or vaping
  • weight loss medication
  • Females who are planning to be pregnant, are pregnant or are breastfeeding
  • Anyone with food allergies, self-reported food sensitivity or intolerance
  • Anyone with coeliac disease or gluten intolerance
  • Anyone taking medication which may affect their appetite
  • Anyone with an eating disorder
  • Anyone with diabetes
  • Anyone with a gastrointestinal disorder, kidney disease, liver disease or gout
  • Anyone suffering from a psychiatric disorder or any type of substance abuse
  • Anyone suffering from unregulated thyroid disease
  • Anyone following a vegetarian or vegan diet
  • Anyone following a current weight loss programme (that may be affecting lifestyle, physical activity \& diet) or undergone gastric band/reduction surgery
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rowett Institute, University of Aberdeen

Aberdeen, AB25 2ZD, United Kingdom

Location

MeSH Terms

Conditions

Appetitive BehaviorWeight Loss

Condition Hierarchy (Ancestors)

Behavior, AnimalBehaviorBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alexandra Johnstone, Prof

    Rowett Institute, University of Aberdeen

    PRINCIPAL INVESTIGATOR
  • Alexander Ross, Dr

    Rowett Institute, University of Aberdeen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2023

First Posted

June 7, 2023

Study Start

May 12, 2023

Primary Completion

December 16, 2024

Study Completion

December 16, 2024

Last Updated

January 7, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations